#USA #Carmel #Syra Health #Population Health #profitability

Syra Health Corp. Posts Strong Results for FY2025

Syra Health Corp. (OTCQB: SYRA), an integrated healthcare solutions company focused on enhancing health outcomes, has revealed its financial performance for the fiscal year 2025, marking a year of significant transformation and growth.

Highlights of FY2025 Financial Results

Revenue Growth

In FY2025, Syra Health saw its population health revenue soar by an impressive 157%, reaching $5.3 million compared to $2.1 million in FY2024. This remarkable growth can largely be attributed to the increasing demand for the company’s high-margin population health offerings, which include vital services such as data analytics and health education.

For the fourth quarter of FY2025, the population health revenue also experienced substantial growth, reflecting a 128% increase year-over-year to $1.3 million from $550K in Q4 2024.

Improved Earnings Performance

The company's earnings per share (EPS) showed meaningful progress, improving to ($0.08) in FY2025 compared to ($0.50) in FY2024. In Q4 2025, the EPS further improved to a net loss of ($0.01), down from ($0.08) in the same quarter of the previous year. These figures highlight the company's solid movement towards achieving profitability.

Decline in Operating Expenses

Syra Health’s total operating expenses fell significantly by 37% to $3.4 million in FY2025 from $5.4 million in FY2024. Specifically, Q4 2025 operating expenses decreased to $727K, indicating effective cost management strategies being implemented by the company.

Net Loss Reduction

The company also reported a 76% reduction in net loss, with figures showing a loss of ($896K) for FY2025 as opposed to ($3.8M) in FY2024. In Q4 2025, net losses were further minimized to ($135K) from ($504K) in the fourth quarter of the prior year, showcasing a robust improvement in the cost structure.

Gross Margin Growth

Improvements in operational efficiency contributed to gross margins increasing to 34.4% in FY2025 from 20.7% in FY2024, a 14 percentage point rise that illustrates the advantages of a quality revenue mix.

Outlook for 2026

Syra Health’s management anticipates reaching profitability by the end of 2026, driven by a sustained demand for its innovative population health solutions, stringent cost control measures, and recent contract wins.

Recent Operational Developments

The year 2025 also marked a strategic shift for Syra Health, as it transitioned from a peripheral healthcare technology provider to a comprehensive healthcare solutions entity. This evolution allows it to offer end-to-end services to government and commercial healthcare clients alike.

Significantly, the company secured a new training contract in Washington state aimed at protecting behavioral health workers from workplace violence, addressing a pressing need in the healthcare sector. Additionally, Syra Health expanded its live-agent HEDIS call center operations to meet increased demand from insurance clients and launched a wellness pilot program in collaboration with a health department in North Carolina.

Moreover, Syra Health is seeking FDA approval for its product, Syrenity, under the FDA's TEMPO pilot program. This positions them favorably for involvement in the forthcoming CMS ACCESS Model initiative set to be launched in July 2026, which is projected to yield improved patient outcomes in the behavioral health realm.

CEO Commentary

Greg Alexander, the CEO of Syra Health, proclaimed that 2025 was a groundbreaking year for the company. He emphasized that the synergistic effect of significant revenue growth alongside aggressive restructuring efforts in costs led to a 76% reduction in net losses and an impressive gross margin increase of 14 percentage points. His confidence in the company's route to profitability by the close of 2026 is underpinned by the successful transition into a holistic healthcare solutions provider and the ongoing commitment of the entire team.

As Syra Health moves forward, it aims to enhance value for shareholders and contribute positively to health outcomes across the communities it serves throughout the United States.